16th Clinical Biomarkers and CDx Summit Europe | Free* for Biopharma!

With IVDR performance study guidance now in force, German reimbursement reforms underway, and NHS England advancing liquid biopsy rollouts, Europe is entering a new era of precision medicine. As novel and digital diagnostics accelerate, the question is no longer whether they enable fit-for-purpose biomarker strategies, but how quickly clinical, regulatory, and commercial systems can keep pace.
 
Amid this momentum, the 16th World Clinical Biomarkers and Companion Diagnostics Summit Europe returns as the region's longest-standing precision medicine forum, bringing together 300+ senior leaders across biopharma, diagnostics, regulation, reimbursement, and healthcare to define biomarker strategies and ensure day-one drug-diagnostic market readiness.
 
Featuring brand-new case studies from 60+ expert speakers, this meeting is the definitive European platform for knowledge exchange and collaboration, removing barriers to faster, more equitable precision healthcare across oncology, neurological, autoimmune, and chronic diseases.